Uptrend Call Working As MAP Pharmaceuticals Stock Rises 64.9% (MAPP)
SmarTrend identified an Uptrend for MAP Pharmaceuticals (NASDAQ:MAPP) on November 23rd, 2012 at $15.11. In approximately 3 months, MAP Pharmaceuticals has returned 64.91% as of today's recent price of $24.91.
MAP Pharmaceuticals share prices have moved between a 52-week high of $24.94 and a 52-week low of $10.54 and are now trading 136% above that low price at $24.90 per share. The 200-day and 50-day moving averages have moved 1.57% higher and 3.99% higher over the past week, respectively.
MAP Pharmaceuticals Inc. is a biopharmaceutical company. The Company develops treatments for respiratory and CNS diseases.
SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of MAP Pharmaceuticals shares.
Log in and add MAP Pharmaceuticals (MAPP) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.
Keywords: spotlights map pharmaceuticals